RSHO vs. CANC

Last updated Apr 1, 2026

Compare and contrast key facts about Tema American Reshoring ETF (RSHO) and Tema Oncology ETF (CANC).

RSHO and CANC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. RSHO is an actively managed fund by Tema. It was launched on May 10, 2023. CANC is an actively managed fund by Tema. It was launched on Aug 14, 2023.

Performance

RSHO vs. CANC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema American Reshoring ETF (RSHO) and Tema Oncology ETF (CANC). The values are adjusted to include any dividend payments, if applicable.

RSHO vs. CANC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
RSHO Tema American Reshoring ETF	12.27%	19.23%	17.28%	28.26%
CANC Tema Oncology ETF	5.69%	42.92%	-5.37%	787.60%

Returns By Period

In the year-to-date period, RSHO achieves a 12.27% return, which is significantly higher than CANC's 5.69% return.

RSHO

• 1D: 4.94%
• 1M: -8.70%
• YTD: 12.27%
• 6M: 16.13%
• 1Y: 47.15%
• 3Y*: —
• 5Y*: —
• 10Y*: —

CANC

• 1D: 4.66%
• 1M: -2.88%
• YTD: 5.69%
• 6M: 27.93%
• 1Y: 52.46%
• 3Y*: 140.00%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RSHO vs. CANC - Expense Ratio Comparison

Both RSHO and CANC have an expense ratio of 0.75%.

RSHO

Tema American Reshoring ETF

CANC

Tema Oncology ETF

Return for Risk

RSHO vs. CANC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RSHO

RSHO Risk / Return Rank: 89
RSHO Sharpe Ratio Rank: 88
RSHO Sortino Ratio Rank: 90
RSHO Omega Ratio Rank: 85
RSHO Calmar Ratio Rank: 91
RSHO Martin Ratio Rank: 91

CANC

CANC Risk / Return Rank: 90
CANC Sharpe Ratio Rank: 89
CANC Sortino Ratio Rank: 90
CANC Omega Ratio Rank: 82
CANC Calmar Ratio Rank: 94
CANC Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RSHO vs. CANC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema American Reshoring ETF (RSHO) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RSHO	CANC	Difference
Sharpe ratio Return per unit of total volatility	1.83	1.94	-0.11
Sortino ratio Return per unit of downside risk	2.55	2.59	-0.05
Omega ratio Gain probability vs. loss probability	1.33	1.32	+0.01
Calmar ratio Return relative to maximum drawdown	3.18	3.86	-0.68
Martin ratio Return relative to average drawdown	11.76	13.76	-2.00
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RSHO vs. CANC - Sharpe Ratio Comparison

The current RSHO Sharpe Ratio is 1.83, which is comparable to the CANC Sharpe Ratio of 1.94. The chart below compares the historical Sharpe Ratios of RSHO and CANC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RSHO	CANC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.83	1.94	-0.11
Sharpe Ratio (All Time) Calculated using the full available price history	1.26	-0.04	+1.30

Correlation

The correlation between RSHO and CANC is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

RSHO vs. CANC - Dividend Comparison

RSHO's dividend yield for the trailing twelve months is around 0.26%, more than CANC's 0.05% yield.

	TTM	2025	2024	2023
RSHO Tema American Reshoring ETF	0.26%	0.30%	0.26%	0.25%
CANC Tema Oncology ETF	0.05%	0.06%	3.00%	0.56%

Drawdowns

RSHO vs. CANC - Drawdown Comparison

The maximum RSHO drawdown since its inception was -27.31%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for RSHO and CANC.

Drawdown Indicators

	RSHO	CANC	Difference
Max Drawdown Largest peak-to-trough decline	-27.31%	-97.53%	+70.22%
Max Drawdown (1Y) Largest decline over 1 year	-14.64%	-12.40%	-2.24%
Current Drawdown Current decline from peak	-10.42%	-56.19%	+45.77%
Average Drawdown Average peak-to-trough decline	-4.43%	-73.91%	+69.48%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.95%	3.61%	+0.34%

Volatility

RSHO vs. CANC - Volatility Comparison

Tema American Reshoring ETF (RSHO) has a higher volatility of 11.13% compared to Tema Oncology ETF (CANC) at 8.36%. This indicates that RSHO's price experiences larger fluctuations and is considered to be riskier than CANC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RSHO	CANC	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.13%	8.36%	+2.77%
Volatility (6M) Calculated over the trailing 6-month period	17.64%	16.34%	+1.30%
Volatility (1Y) Calculated over the trailing 1-year period	25.94%	27.24%	-1.30%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.91%	285.66%	-263.75%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.91%	285.66%	-263.75%